Oliver Rausch
Mission Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
interferon and immune responses, Cytokine Signaling Pathways and Interactions, Cancer-related molecular mechanisms research, RNA modifications and cancer, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia(2021)1,281 cited
- → Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription(2000)888 cited
- → A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation(2012)143 cited
- → Discovering Language Model Behaviors with Model-Written Evaluations(2023)119 cited
- → Deep and accurate detection of m6A RNA modifications using miCLIP2 and m6Aboost machine learning(2021)113 cited
- → Cooperation of p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways during Granulocyte Colony-stimulating Factor-induced Hemopoietic Cell Proliferation(1999)108 cited
- → Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity(2023)106 cited
- → CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks(2008)90 cited
- → Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons(2003)87 cited
- → Tyrosine 763 of the Murine Granulocyte Colony-Stimulating Factor Receptor Mediates Ras-Dependent Activation of the JNK/SAPK Mitogen-Activated Protein Kinase Pathway(1997)84 cited